mRNA Vaccine Promising for Pancreatic Cancer
(MedPage Today) -- A personalized mRNA vaccine, used in combination with an immune checkpoint inhibitor and chemotherapy after surgery, induced an immune response in half of treated patients with pancreatic ductal adenocarcinoma (PDAC), a small...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Cancer Vaccines | Chemotherapy | Gastroenterology | Pancreas | Pancreatic Cancer | Vaccines